Raia Drogasil (RADLY) Projected to Post Earnings on Tuesday

Raia Drogasil (OTCMKTS:RADLY) is projected to announce its results after the market closes on Tuesday, November 3rd. Analysts expect Raia Drogasil to announce earnings of $0.05 per share and revenue of $2.41 billion for the quarter.

Raia Drogasil (OTCMKTS:RADLY) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.05. Raia Drogasil had a return on equity of 20.12% and a net margin of 2.99%. The business had revenue of $2.17 billion during the quarter, compared to analyst estimates of $2.32 billion. On average, analysts expect Raia Drogasil to post $0.17 EPS for the current fiscal year and $0.24 EPS for the next fiscal year.

Raia Drogasil Stock Performance

OTCMKTS:RADLY opened at $2.76 on Monday. The firm has a market capitalization of $3.63 billion and a PE ratio of 18.40. Raia Drogasil has a 1 year low of $2.74 and a 1 year high of $5.34. The firm’s fifty day simple moving average is $3.75 and its 200 day simple moving average is $4.08. The company has a current ratio of 1.41, a quick ratio of 0.58 and a debt-to-equity ratio of 0.99.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group raised Raia Drogasil to a “buy” rating and set a $5.20 target price for the company in a research note on Sunday, October 18th. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $5.20.

Raia Drogasil Company Profile

Raia Drogasil, now operating under the name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a network of pharmacies offering prescription medicines, over-the-counter drugs, vitamins, personal care products, beauty items and other health-related merchandise.

The company also provides digital purchasing and delivery services through its online channels, supporting customers with prescription fulfillment, health products and related services. Its operations include pharmacy-based healthcare initiatives designed to complement its retail business and improve access to everyday healthcare.

RD Saúde was created in 2011 through the merger of Drogasil and Droga Raia, two established Brazilian pharmacy chains.